Gold, J;
Marta, M;
Meier, UC;
Christensen, T;
Miller, D;
Altmann, D;
Holden, D;
... Giovannoni, G; + view all
(2018)
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.
Multiple Sclerosis and Related Disorders
, 24
pp. 123-128.
10.1016/j.msard.2018.06.002.